Cotrimoxazole resistance in Streptococcus pneumoniae isolated from sputum of HIV-positive patients

West Indian Medical Journal

Volumn 57, Issue 5, 2008, Pages 497-499

  Adeleye, A ^a   Uju, L ^a   Idika, N ^a   Sobande, O ^b  

^a UNIVERSITY OF LAGOS   (Nigeria)

^b Yaba College of Technology   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CHLORAMPHENICOL; CLOXACILLIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; DRUG CHOICE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; SCHOOL CHILD; SENSITIVITY ANALYSIS; SPUTUM ANALYSIS; STREPTOCOCCUS PNEUMONIA; COMPLICATION; DRUG EFFECTS; HEALTH SURVEY; HIV INFECTIONS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; NIGERIA; PNEUMOCOCCAL INFECTIONS; SPUTUM; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ADULT; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NIGERIA; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; SPUTUM; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 65249098241     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Cohen PT, Sande MA, Volberding PA. The AIDS knowledge base. 2nd Ed, Little, Brown and Company, Boston/New York, Toronto/London 1994: 6.2-1-6.2.-12.
2. Redd SC, Rutherford GW 3rd, Sande MA, Lifson AR, Hadley WK, Facklam RR et al. The role of human immunodeificiency virus infection in pneumococcal bacteremia in San Francisco residence. J Infect Dis 1990; 162: 1012-7.
3. Plouffe JF, Breiman RF, Facklam RR. Bacteremia with Streptococcus pneumoniae. JAMA 1996; 275: 194-8.
4. Hart CA, Beeching NJ, Duerden BI, Curry A, French N, Kariuki S et al. Infection in AIDS. J Med Microbiol 2000; 49: 947-67,
5. Gilks CF, Ojoo SA, Ojoo JC, Brindle RJ, Paul J, Batchelor BI et al. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex workers in Natrobi, Kenya. Lancet 1996; 346: 718-23.
6. Jankelevich S. Serious Bacterial infections in children with HIV. HIV Insite knowledge Base Chapter http://hivinsite.ucsf.edu// insite?page=kb-05-01-01-01.
7. WHO Technical Reports Series. WHO expert Consultation on Cotrimoxazole pophylaxix in HIV infection; Geneva, 10-12 May 10-12 2005.
8. Fieldland IR, McCracken GH. Management of infections caused by antibiotic - resistant Streptococcus pneumoniae. N Engl J Med 1994; 331: 337-82.
9. Cowan ST, Steele J.K. Manual for the identification of medical bacteria. Camb Univ Press Camb. 1974; 51-55.
10. Bauer AW, Kirby WM, Sherris JC, Turek M. Antibiotic susceptibility testing by standardized single disk method. Am J Clin Pathol 1966; 45: 493-6.
11. Akinsete I, Akanmu AS, Okany CC. Spectrum of clinical diseases in HIV infected adults at the Lagos University Teaching Hospital: a five-year experience (1992-1996). Afr J Med Sci 1998; 28: 147-51.
12. Idika N, Aniedebe M, Onwujekwe D, Idogbe O, Okany C, Ekong G et al. The prevalence of drug resistant S. pneumoniae isolates in respiratory opportunistic infections in HIV and AIDS in Lagos, Nigeria. (Yet to be published data).
13. Agwu E, Ohihion AA, Agba MI, Okogun GR, Okodua N, Tat Feng YM et al. Incidence of S pneumoniae infections among patients attending tuberculosis clinics in Ekpoma, Nigeria. Shiraz E-Med J 2006; 7: 1-11
14. Meynard Jr, Barbut F, Blum L. Risk factors for isolation of Streptococcus pneumoniae with decreased susceptibility to penicillin G from patients infected with human immunodeficiency virus. Clin Infect Dis 1996; 22: 437-40.
15. Johnson JP, Nair P, Hines S, Seiden SW, Alger L, Revie DR et al. Natural history and serologic diagnosis of infants born to human immunodeficiency syndrome virus infected women. Ann J Dis Child 1989; 143: 1147-53.
16. Garau J, Twynholm M, Garcia-Mendez E, Siquier B, River A; 557 Clinical Study Group. Oral pharmacokinetically enhanced co-amoxiclay 2000/125 mg, in the treatment of community - acquired pneumonia in European adults. J Antimicrob Chemother 2003; 52: 826-36.
17. Farrell DJ, Jenkins SG, Reinert RR. Global distribution of Streptococcus pneumoniae serotypes isolated from paediatric patients during 1999-2000 and the in vitro efficacy of telithromycin and comparators. J Med Microbiol 2004; 53: 1109-17.
18. Feikin DR. Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine. J Infect Dis 2000; 181: 1501-5.